In an independent review, Chemical company Orica has shared the actual cause of the chemical leakage accident occurred last month on August 8. Done by consulting firm Johnson Matthey, the embattled company had been under scanner to ensure that accountability is being set, lack of which is believed to have triggered the leak of hexavalent chromium from Orica's ammonium nitrate plant at nearby Kooragang Island.

Fairwealth Securities is bullish on Lupin Limited and has maintained 'buy' rating on the stock to attain a target of Rs 450.

The stock of the company, on March 21, closed at Rs 403.75 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 519.80 and a low of Rs 319.80 on BSE.

Current EPS & P/E ratio stood at 19.19 and 21.31 respectively.

The US District Court of New Jersey has cleared up the decks for the country's second-biggest pharmaceutical manufacturer, Dr Reddy's Laboratories, to roll out a generic edition of Allegra-D 24 pills in the US market.

Drug manufacturer Ranbaxy Laboratories announced that its president and chief financial officer (CFO) Omesh Sethi has quitted from the company's services.

In a declaration, the company said, "Omesh Sethi, president and chief financial officer has resigned from the services of the company, with effect from January 25, 2011."

But, Ranbaxy did not mention any cause behind Sethi's exit.

Glenmark Generics (GGI), the US-based arm of Glenmark Generics (GGL),, declared the United States Food and Drug Administration (USFDA) has granted nod for 3 Abbreviated New Drug Applications (ANDA).

Final ANDA authorizations were bagged for Indomethacin 25 mg and 50 mg caps, USP and Sulfamethoxazole and Trimethoprim double and single strength tabs.

Driven by an increase in sales in the United States, India's biggest drug manufacturer Ranbaxy recorded a more than two fold jump in its net profit, which stood at 312.8 crore for the three month period ended September 30.

Ranbaxy, which made a net profit of 116.6 crore during July-Sep 2009, also gained from constructive Forex movement duirng the third quarter.

World's leading generic pharmaceutical firm Cipla becomes the first from the country to bag The Australian Pesticides and Veterinary Medicines Authority (APVMA) nod for launching its generic omeprazole in the Australian market.

The generic omeprazole can be used for the treatment of equine ulcers.

Aurobindo Pharma Ltd has inked licensing and supply deals with pharmaceutical firm AstraZeneca in order to supply finished dose and sterile products to growing market zones.

Pharma giant, GlaxoSmithkline Consumer Healthcare Ltd has declared that it has bagged final nod from USFDA for Naratriptan Hydrochloride tabs.

The company got nod to sell the tablets in the potencies of 2.5mg base and 1mg base.

Naratriptan hydrochloride pills are prescribed by the physician to put control over migraine attacks in grownups with or without aura.

The parliamentary standing group on health has asked the administration to be cautious about the selling out of major Indian pharmas to multinational corporations, whose growing hold on the drug market it said will make vital medications pricier.